A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen

The discovery of pharmacogenomic markers in colorectal cancer (CRC) could be setting-specific. FOLFOX4 is employed in the adjuvant and metastatic setting in CRC. This prospective study is aimed to validate in the adjuvant setting the pharmacogenomic markers of toxicity reported in the metastatic set...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cecchin, E, D’Andrea, M, Lonardi, S, Zanusso, C, Pella, N, Errante, D, De Mattia, E, Polesel, J, Innocenti, F, Toffoli, G
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859145/
https://ncbi.nlm.nih.gov/pubmed/22868256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2012.31
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados